Nath Bio-Genes (India) has informed that the 31st AGM of the Members of the Company held on 17th August 2024 at 11:00 am via video conferencing/other audio-visual means. The below mentioned items of the Business Contained in the Notice of Annual General Meeting approved by the Shareholders: Ordinary Business - 1. To receive, consider and adopt the Audited Balance Sheet of the Company as of March 31, 2024, and Statement of Profit & Loss for the year ended as on that date together with the Reports of Directors and Auditors thereon. 2. To declare a Final Dividend of ? 2 per equity shares of face value of ? 10 each for financial year ended 31st March 2024. 3. To appoint Jeevanlata Kagliwal (DIN-02057459) as Director of the Company, who retires by rotation and being eligible, offer herself for re-appointment. All the above resolutions were passed with the requisite majority. Proceedings of AGM, Scrutinizers Report and Voting Results will be uploaded separately.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Venkys India | 1478.75 |
| Mangalam Global Ent | 12.55 |
| Kaveri Seed | 927.05 |
| Regaal Resources | 78.46 |
| Simran Farms | 156.05 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: